[Editor's Note: This is part one of a three-part "UK Outlook 2018" series including insights from ABHI, the UK medtech industry association. Upcoming pieces will focus on Brexit, innovation and the life sciences deal; and market access and the Accelerated Access Review.]
UK government preparations for Brexit – however unstructured – dominate business thinking, even though cabinet EU strategists have thus far been unable to set the agenda for future trade relationships...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?